Evogene Schedules Second Quarter 2025 Financial Results Release

About this update from Evogene Ltd.

Zoom conference call scheduled for August 19, 2025 , 9:00 AM ET REHOVOT, Israel , July 29, 2025 /PRNewswire/ -- Evogene Ltd . (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development, announced today that it will release its financial results for the first quarter of 2025, on Tuesday , August 19 , 2025 .   Later that day, Company management will host a conference call to discuss the results at 9:00 AM Eastern Time ( 4:00 PM Israel time). To attend the conference, please register in advance: https://www.veidan-conferencing.com/evogene The entire conference will be available online on the company's website a few days after. About Evogene: Evogene Ltd. (Nasdaq, TASE: EVGN) is a computational biology company leveraging big data and artificial intelligence, aiming to revolutionize the development of life-science-based products by utilizing cutting-edge technologies to increase the probability of success while reducing development time and cost. Evogene established three unique tech-engines - MicroBoost  AI ,  ChemPass AI  and  GeneRator AI . Each tech-engine is focused on the discovery and development of products based on one of the following core components: microbes ( MicroBoost AI ), small molecules ( ChemPass AI ), and genetic elements ( GeneRator AI ). Evogene uses its tech-engines to develop products through strategic partnerships and collaborations, and its subsidiaries, including: For more information, please visit: www.evogene.com . Contact: [email protected] Tel: +972-8-9311901 Logo: https://mma.prnewswire.com/media/1947468/4576969/Evogene_Logo.jpg View original content: https://www.prnewswire.com/news-releases/evogene-schedules-second-quarter-2025-financial-results-release-302515858.html SOURCE Evogene

View stock analysis, news, and events for Evogene Ltd.